Clinical studies recruiting near Newport Beach

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pe
Phase 1 · USC Norris Oncology/Hematology-Newport Beach · National Cancer Institute (NCI) · NCT05372640 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · USC Norris Oncology/Hematology-Newport Beach · NRG Oncology · NCT06532279 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · USC Norris Oncology/Hematology-Newport Beach · NRG Oncology · NCT05174169 A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4 · Hoag Hospital Newport Beach · Takeda · NCT06095128 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06876714 A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Phase N/A · Newport Native MD, Inc. - Site Number: 840101 · Sanofi · NCT07556159 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · City of Hope Newport Beach · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · USC Norris Oncology/Hematology-Newport Beach · Canadian Cancer Trials Group · NCT06592924 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · NRG Oncology · NCT06748222 WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2 · WISPer site in Newport Beach, CA · Mediar Therapeutics · NCT06967805 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Phase 3 · Ardelyx · NCT07382167 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · USC Norris Oncology/Hematology-Newport Beach · Alliance for Clinical Trials in Oncology · NCT05677490 A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Phase 2/Phase 3 · USC Newport Beach · Linnaeus Therapeutics, Inc. · NCT06624644 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · City of Hope Newport Beach · National Cancer Institute (NCI) · NCT06058377 Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Phase 3 · Hoag Hospital Newport Beach · Nuvalent Inc. · NCT06765109 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · USC Norris Oncology/Hematology-Newport Beach · National Cancer Institute (NCI) · NCT05987241 Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Phase N/A · Boston Scientific Corporation · NCT04674969 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · City of Hope Newport Beach · National Cancer Institute (NCI) · NCT05675410 A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication U
Phase N/A · City of Hope at Newport Beach Fashion Island · City of Hope Medical Center · NCT07225738 A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acu
Phase 2 · National Cancer Institute (NCI) · NCT04546399 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · City of Hope Newport Beach · SWOG Cancer Research Network · NCT03418961 Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cance
NA · City of Hope at Newport Beach Fashion Island · City of Hope Medical Center · NCT07125729 Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta
Phase 2 · USC Norris Oncology/Hematology-Newport Beach · National Cancer Institute (NCI) · NCT06029270 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · USC Norris Oncology/Hematology-Newport Beach · SWOG Cancer Research Network · NCT03723928 Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe
Phase 3 · USC Norris Oncology/Hematology-Newport Beach · National Cancer Institute (NCI) · NCT06422806 Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Phase 2 · City of Hope at Newport Beach Fashion Island · City of Hope Medical Center · NCT04508790 Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · USC Norris Oncology/Hematology-Newport Beach · National Cancer Institute (NCI) · NCT03866382 Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatmen
Phase 2 · City of Hope at Newport Beach Fashion Island · City of Hope Medical Center · NCT07288034 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · SWOG Cancer Research Network · NCT03851445 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · National Cancer Institute (NCI) · NCT07061977

Look up another city

Look up another condition